Patienten die chemotherapie krijgen voor mamma-, ovarium-, hodgkin-, non-hodgkin Nausea vomiting
Conditions
Interventions
The control group will receive standard verbal and written information about
the anti-emetica schedule.
The intervention group will use the NCA an application, developed for
smart-phone-using oncol
Sponsors
Oncologie
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Adulta (18+) - Diagnosed with oncologic disease - Precription with AC, TAC, R-CHOP, ABVD, Taxol/Carboplatin - Able to read and speake Dutch - Own a smartphone (Iphone, Android) - Capable to give written informed consent
Exclusion criteria
Exclusion criteria: - Patient who received chemotherapy prior to study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter include differences between NCAG and CG, regarding: Chemotherapy induced nausea measured as a patient reported visual analoge scale (VAS) and defined as a VAS equal or above 5 mm. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Number of days including occurence of nausea. - Number of days including occurrence of vomiting - Number of days including usage of escape medication - QoL-scores Numbers and percentages of NCAG who: - find the NCA easy to download - find the instructions clearly described - received information as requested - find the NCA useful as a reminder for taking anti-emetics - would recommend the NCA to other patients Contacting the ward by NCAG and CG: - number of days including extra visits - number of days including extra phone calls | — |
Countries
Netherlands
Outcome results
None listed